Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. ZEPATIER (elbasvir/grazoprévir), association fixe d’antiviraux à action directe
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ZEPATIER (elbasvir/grazoprévir), association fixe d’antiviraux à action directe

Medicine - Posted on Jan 10 2024
Active substance (DCI)
  • elbasvir
  • grazoprévir
history (3)
  • 11/17/21

    ZEPATIER (elbasvir/grazoprévir) - Hépatite C chez les adolescents à partir de 12 ans

    Le laboratoire a informé la HAS de sa demande de non remboursement dans l’indication « Traitement de l’hépatite C chronique ...
    icône flèche
  • 10/20/21

    ZEPATIER (grazoprévir monohydraté/ elbasvir)

    Réévaluation. La Commission a examiné les résultats finaux de l’étude post-inscription évaluant l’utilisation des antiviraux...
    icône flèche
  • 10/19/16

    ZEPATIER (elbasvir grazoprevir), fixed combination of direct-acting antivirals

    Minor clinical added value, like other direct-acting antivirals (HARVONI, DAKLINZA, OLYSIO, VIEKIRAX, EXVIERA), in the treat...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • J05AP54
Manufacturer
MSD FRANCE
Presentation

ZEPATIER 50 mg/100 mg, comprimé pelliculé (code CIS : 66198173)
4 plaquette(s) aluminium de 7 comprimé(s) (CIP : 34009 30 0617 0 1)

All our publications
    Drug therapy Liver diseases Virus diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
UPwFCjXmgfBN897c